Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL678P is a processed pseudogene derived from the active 7SL RNA gene (RN7SL1). The 7SL RNA family serves as the RNA backbone in the signal recognition particle (SRP) complex, crucial for co-translational protein targeting to the endoplasmic reticulum (ER) in eukaryotic cells. However, RN7SL678P is merely a genomic remnant, typically formed by reverse transcription and insertion of the 7SL RNA sequence into the genome, and it does not encode a functional RNA or protein product. While some pseudogenes are transcribed and may have regulatory roles (such as miRNA decoy or source of small interfering RNAs), there is no evidence for functional molecules, disease association, or drug-interaction properties specific to RN7SL678P.
Not applicable, since this is not a protein or functional RNA with a defined targetable mechanism.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 678, pseudogene (RN7SL678P).